Flagship Pioneering has unveiled a new start-up that aims to find, then drug, targets that are specific to different states of diseases. The company, Etiome, will begin with metabolic, ...

Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) - ...

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

The active immunotherapy developed at UNM generates antibodies that bind to pT181, a region of the altered tau protein that has been identified as an Alzheimer's biomarker. In a 2019 paper ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of ...

Phosphorylation enables tau protein to undergo reversible liquid–liquid phase separation (LLPS), forming micrometer-sized droplets, a property not seen in unmodified tau.

Those findings were integrated with data collected from the participants on cerebrospinal fluid and brain-scan biomarkers of amyloid- β and tau protein, cognitive function, age, sex and Alzheimer ...

Plasma eMTBR-tau243 shows a strong correlation with tau pathology and cognitive decline, offering a less invasive alternative to tau-PET imaging. Study: Plasma MTBR-tau243 biomarker identifies tau ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau -- a protein in the brain ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.